REVUE 08/09.book

A series of six palatability studies, employing acceptance (three studies) and preference (three studies) tests, were used to compare the voluntary acceptance, preference and consumption of a palatable formulation of carprofen (Rimadyl® Chewable Tablets or Rimadyl® Palatable Tablets; Pfizer Animal Health) with those of two generic formulations of carprofen (Carprodyl® Tablets; Ceva and Norocarp® Tablets; Norbrook) and a formulation of firocoxib (Previcox® Chewable Tablets; Mérial), respectively. All the studies took place at the same kennels and each involved dogs of various and mixed breeds with ages ranging from one to 11 years. Rimadyl® consistently demonstrated significantly better palatability in terms of voluntary choice, prehension and full consumption when compared with each of the other three products Carprodyl®, Norocarp® and Previcox®.